nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—Calcitriol—psoriasis	0.102	0.191	CbGbCtD
Rifaximin—CYP3A4—Methoxsalen—psoriasis	0.0792	0.149	CbGbCtD
Rifaximin—CYP3A4—Cholecalciferol—psoriasis	0.0525	0.0986	CbGbCtD
Rifaximin—CYP3A4—Mycophenolate mofetil—psoriasis	0.0455	0.0855	CbGbCtD
Rifaximin—CYP3A4—Triamcinolone—psoriasis	0.0455	0.0855	CbGbCtD
Rifaximin—CYP3A4—Betamethasone—psoriasis	0.039	0.0733	CbGbCtD
Rifaximin—CYP3A4—Prednisolone—psoriasis	0.0385	0.0724	CbGbCtD
Rifaximin—CYP3A4—Hydrocortisone—psoriasis	0.0365	0.0686	CbGbCtD
Rifaximin—CYP3A4—Prednisone—psoriasis	0.0364	0.0683	CbGbCtD
Rifaximin—CYP3A4—Cyclosporine—psoriasis	0.0345	0.0648	CbGbCtD
Rifaximin—CYP3A4—Dexamethasone—psoriasis	0.0227	0.0427	CbGbCtD
Rifaximin—Malaise—Dexamethasone—psoriasis	0.000245	0.000524	CcSEcCtD
Rifaximin—Malaise—Betamethasone—psoriasis	0.000245	0.000524	CcSEcCtD
Rifaximin—Anaphylactic shock—Triamcinolone—psoriasis	0.000245	0.000523	CcSEcCtD
Rifaximin—Vertigo—Dexamethasone—psoriasis	0.000245	0.000523	CcSEcCtD
Rifaximin—Vertigo—Betamethasone—psoriasis	0.000245	0.000523	CcSEcCtD
Rifaximin—Syncope—Betamethasone—psoriasis	0.000244	0.000522	CcSEcCtD
Rifaximin—Syncope—Dexamethasone—psoriasis	0.000244	0.000522	CcSEcCtD
Rifaximin—Pain—Mycophenolate mofetil—psoriasis	0.000244	0.000521	CcSEcCtD
Rifaximin—Constipation—Mycophenolate mofetil—psoriasis	0.000244	0.000521	CcSEcCtD
Rifaximin—Infection—Triamcinolone—psoriasis	0.000243	0.00052	CcSEcCtD
Rifaximin—Hypotension—Hydrocortisone—psoriasis	0.000243	0.000519	CcSEcCtD
Rifaximin—Haematuria—Methotrexate—psoriasis	0.000242	0.000516	CcSEcCtD
Rifaximin—Feeling abnormal—Cyclosporine—psoriasis	0.000241	0.000515	CcSEcCtD
Rifaximin—Shock—Triamcinolone—psoriasis	0.000241	0.000515	CcSEcCtD
Rifaximin—Insomnia—Prednisolone—psoriasis	0.000241	0.000515	CcSEcCtD
Rifaximin—Gastrointestinal pain—Cyclosporine—psoriasis	0.000239	0.000511	CcSEcCtD
Rifaximin—Loss of consciousness—Dexamethasone—psoriasis	0.000239	0.000511	CcSEcCtD
Rifaximin—Loss of consciousness—Betamethasone—psoriasis	0.000239	0.000511	CcSEcCtD
Rifaximin—Dizziness—Mycophenolic acid—psoriasis	0.000239	0.000511	CcSEcCtD
Rifaximin—Epistaxis—Methotrexate—psoriasis	0.000239	0.000511	CcSEcCtD
Rifaximin—Mental disorder—Prednisone—psoriasis	0.000239	0.00051	CcSEcCtD
Rifaximin—Malnutrition—Prednisone—psoriasis	0.000237	0.000507	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000237	0.000506	CcSEcCtD
Rifaximin—Hyperhidrosis—Triamcinolone—psoriasis	0.000237	0.000506	CcSEcCtD
Rifaximin—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000235	0.000503	CcSEcCtD
Rifaximin—Insomnia—Hydrocortisone—psoriasis	0.000235	0.000502	CcSEcCtD
Rifaximin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000233	0.000499	CcSEcCtD
Rifaximin—Urticaria—Cyclosporine—psoriasis	0.000232	0.000497	CcSEcCtD
Rifaximin—Myalgia—Dexamethasone—psoriasis	0.000232	0.000495	CcSEcCtD
Rifaximin—Myalgia—Betamethasone—psoriasis	0.000232	0.000495	CcSEcCtD
Rifaximin—Abdominal pain—Cyclosporine—psoriasis	0.000231	0.000494	CcSEcCtD
Rifaximin—Body temperature increased—Cyclosporine—psoriasis	0.000231	0.000494	CcSEcCtD
Rifaximin—Vomiting—Mycophenolic acid—psoriasis	0.00023	0.000491	CcSEcCtD
Rifaximin—Discomfort—Betamethasone—psoriasis	0.000229	0.000489	CcSEcCtD
Rifaximin—Discomfort—Dexamethasone—psoriasis	0.000229	0.000489	CcSEcCtD
Rifaximin—Haemoglobin—Methotrexate—psoriasis	0.000229	0.000489	CcSEcCtD
Rifaximin—Rash—Mycophenolic acid—psoriasis	0.000228	0.000487	CcSEcCtD
Rifaximin—Dermatitis—Mycophenolic acid—psoriasis	0.000228	0.000487	CcSEcCtD
Rifaximin—Pain—Prednisolone—psoriasis	0.000228	0.000486	CcSEcCtD
Rifaximin—Haemorrhage—Methotrexate—psoriasis	0.000228	0.000486	CcSEcCtD
Rifaximin—Urticaria—Mycophenolate mofetil—psoriasis	0.000227	0.000484	CcSEcCtD
Rifaximin—Headache—Mycophenolic acid—psoriasis	0.000227	0.000484	CcSEcCtD
Rifaximin—Decreased appetite—Hydrocortisone—psoriasis	0.000226	0.000483	CcSEcCtD
Rifaximin—Pharyngitis—Methotrexate—psoriasis	0.000226	0.000483	CcSEcCtD
Rifaximin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000226	0.000482	CcSEcCtD
Rifaximin—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000226	0.000482	CcSEcCtD
Rifaximin—Urinary tract disorder—Methotrexate—psoriasis	0.000225	0.00048	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000224	0.00048	CcSEcCtD
Rifaximin—Fatigue—Hydrocortisone—psoriasis	0.000224	0.000479	CcSEcCtD
Rifaximin—Urethral disorder—Methotrexate—psoriasis	0.000223	0.000477	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000223	0.000477	CcSEcCtD
Rifaximin—Pain—Hydrocortisone—psoriasis	0.000222	0.000475	CcSEcCtD
Rifaximin—Anaphylactic shock—Dexamethasone—psoriasis	0.000222	0.000475	CcSEcCtD
Rifaximin—Anaphylactic shock—Betamethasone—psoriasis	0.000222	0.000475	CcSEcCtD
Rifaximin—Insomnia—Triamcinolone—psoriasis	0.000221	0.000473	CcSEcCtD
Rifaximin—Infection—Betamethasone—psoriasis	0.000221	0.000472	CcSEcCtD
Rifaximin—Infection—Dexamethasone—psoriasis	0.000221	0.000472	CcSEcCtD
Rifaximin—Ill-defined disorder—Prednisone—psoriasis	0.00022	0.00047	CcSEcCtD
Rifaximin—Feeling abnormal—Prednisolone—psoriasis	0.000219	0.000469	CcSEcCtD
Rifaximin—Anaemia—Prednisone—psoriasis	0.000219	0.000468	CcSEcCtD
Rifaximin—Shock—Dexamethasone—psoriasis	0.000219	0.000467	CcSEcCtD
Rifaximin—Shock—Betamethasone—psoriasis	0.000219	0.000467	CcSEcCtD
Rifaximin—Dyspnoea—Triamcinolone—psoriasis	0.000218	0.000466	CcSEcCtD
Rifaximin—Nervous system disorder—Dexamethasone—psoriasis	0.000218	0.000465	CcSEcCtD
Rifaximin—Nervous system disorder—Betamethasone—psoriasis	0.000218	0.000465	CcSEcCtD
Rifaximin—Angioedema—Prednisone—psoriasis	0.000217	0.000463	CcSEcCtD
Rifaximin—Hypersensitivity—Cyclosporine—psoriasis	0.000216	0.000461	CcSEcCtD
Rifaximin—Nausea—Mycophenolic acid—psoriasis	0.000215	0.000459	CcSEcCtD
Rifaximin—Hyperhidrosis—Dexamethasone—psoriasis	0.000215	0.000459	CcSEcCtD
Rifaximin—Hyperhidrosis—Betamethasone—psoriasis	0.000215	0.000459	CcSEcCtD
Rifaximin—Feeling abnormal—Hydrocortisone—psoriasis	0.000214	0.000458	CcSEcCtD
Rifaximin—Malaise—Prednisone—psoriasis	0.000214	0.000457	CcSEcCtD
Rifaximin—Vertigo—Prednisone—psoriasis	0.000213	0.000455	CcSEcCtD
Rifaximin—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000213	0.000454	CcSEcCtD
Rifaximin—Syncope—Prednisone—psoriasis	0.000213	0.000454	CcSEcCtD
Rifaximin—Tinnitus—Methotrexate—psoriasis	0.000212	0.000453	CcSEcCtD
Rifaximin—Anorexia—Dexamethasone—psoriasis	0.000212	0.000452	CcSEcCtD
Rifaximin—Anorexia—Betamethasone—psoriasis	0.000212	0.000452	CcSEcCtD
Rifaximin—Urticaria—Prednisolone—psoriasis	0.000211	0.000452	CcSEcCtD
Rifaximin—Fatigue—Triamcinolone—psoriasis	0.000211	0.000451	CcSEcCtD
Rifaximin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.00021	0.000449	CcSEcCtD
Rifaximin—Asthenia—Cyclosporine—psoriasis	0.00021	0.000449	CcSEcCtD
Rifaximin—Pain—Triamcinolone—psoriasis	0.000209	0.000447	CcSEcCtD
Rifaximin—Loss of consciousness—Prednisone—psoriasis	0.000208	0.000445	CcSEcCtD
Rifaximin—Hypotension—Betamethasone—psoriasis	0.000208	0.000444	CcSEcCtD
Rifaximin—Hypotension—Dexamethasone—psoriasis	0.000208	0.000444	CcSEcCtD
Rifaximin—Pruritus—Cyclosporine—psoriasis	0.000207	0.000442	CcSEcCtD
Rifaximin—Urticaria—Hydrocortisone—psoriasis	0.000207	0.000441	CcSEcCtD
Rifaximin—Angiopathy—Methotrexate—psoriasis	0.000206	0.000441	CcSEcCtD
Rifaximin—Abdominal pain—Hydrocortisone—psoriasis	0.000206	0.000439	CcSEcCtD
Rifaximin—Body temperature increased—Hydrocortisone—psoriasis	0.000206	0.000439	CcSEcCtD
Rifaximin—Mediastinal disorder—Methotrexate—psoriasis	0.000205	0.000438	CcSEcCtD
Rifaximin—Asthenia—Mycophenolate mofetil—psoriasis	0.000205	0.000438	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000202	0.000432	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000202	0.000432	CcSEcCtD
Rifaximin—Pruritus—Mycophenolate mofetil—psoriasis	0.000202	0.000431	CcSEcCtD
Rifaximin—Myalgia—Prednisone—psoriasis	0.000202	0.000431	CcSEcCtD
Rifaximin—Arthralgia—Prednisone—psoriasis	0.000202	0.000431	CcSEcCtD
Rifaximin—Feeling abnormal—Triamcinolone—psoriasis	0.000202	0.000431	CcSEcCtD
Rifaximin—Insomnia—Betamethasone—psoriasis	0.000201	0.000429	CcSEcCtD
Rifaximin—Insomnia—Dexamethasone—psoriasis	0.000201	0.000429	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.0002	0.000428	CcSEcCtD
Rifaximin—Diarrhoea—Cyclosporine—psoriasis	0.0002	0.000428	CcSEcCtD
Rifaximin—Discomfort—Prednisone—psoriasis	0.000199	0.000426	CcSEcCtD
Rifaximin—Mental disorder—Methotrexate—psoriasis	0.000199	0.000426	CcSEcCtD
Rifaximin—Malnutrition—Methotrexate—psoriasis	0.000198	0.000423	CcSEcCtD
Rifaximin—Hypersensitivity—Prednisolone—psoriasis	0.000196	0.000419	CcSEcCtD
Rifaximin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000195	0.000417	CcSEcCtD
Rifaximin—Urticaria—Triamcinolone—psoriasis	0.000194	0.000416	CcSEcCtD
Rifaximin—Body temperature increased—Triamcinolone—psoriasis	0.000194	0.000414	CcSEcCtD
Rifaximin—Dizziness—Cyclosporine—psoriasis	0.000193	0.000413	CcSEcCtD
Rifaximin—Anaphylactic shock—Prednisone—psoriasis	0.000193	0.000413	CcSEcCtD
Rifaximin—Decreased appetite—Betamethasone—psoriasis	0.000193	0.000413	CcSEcCtD
Rifaximin—Decreased appetite—Dexamethasone—psoriasis	0.000193	0.000413	CcSEcCtD
Rifaximin—Infection—Prednisone—psoriasis	0.000192	0.000411	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000192	0.00041	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000192	0.00041	CcSEcCtD
Rifaximin—Back pain—Methotrexate—psoriasis	0.000192	0.000409	CcSEcCtD
Rifaximin—Hypersensitivity—Hydrocortisone—psoriasis	0.000192	0.000409	CcSEcCtD
Rifaximin—Fatigue—Dexamethasone—psoriasis	0.000191	0.000409	CcSEcCtD
Rifaximin—Fatigue—Betamethasone—psoriasis	0.000191	0.000409	CcSEcCtD
Rifaximin—Shock—Prednisone—psoriasis	0.00019	0.000407	CcSEcCtD
Rifaximin—Pain—Dexamethasone—psoriasis	0.00019	0.000406	CcSEcCtD
Rifaximin—Pain—Betamethasone—psoriasis	0.00019	0.000406	CcSEcCtD
Rifaximin—Nervous system disorder—Prednisone—psoriasis	0.00019	0.000405	CcSEcCtD
Rifaximin—Dizziness—Mycophenolate mofetil—psoriasis	0.000189	0.000403	CcSEcCtD
Rifaximin—Skin disorder—Prednisone—psoriasis	0.000188	0.000402	CcSEcCtD
Rifaximin—Hyperhidrosis—Prednisone—psoriasis	0.000187	0.0004	CcSEcCtD
Rifaximin—Asthenia—Hydrocortisone—psoriasis	0.000187	0.000399	CcSEcCtD
Rifaximin—Vomiting—Cyclosporine—psoriasis	0.000186	0.000397	CcSEcCtD
Rifaximin—Rash—Cyclosporine—psoriasis	0.000184	0.000394	CcSEcCtD
Rifaximin—Anorexia—Prednisone—psoriasis	0.000184	0.000394	CcSEcCtD
Rifaximin—Dermatitis—Cyclosporine—psoriasis	0.000184	0.000394	CcSEcCtD
Rifaximin—Pruritus—Hydrocortisone—psoriasis	0.000184	0.000393	CcSEcCtD
Rifaximin—Ill-defined disorder—Methotrexate—psoriasis	0.000184	0.000393	CcSEcCtD
Rifaximin—Headache—Cyclosporine—psoriasis	0.000183	0.000392	CcSEcCtD
Rifaximin—Anaemia—Methotrexate—psoriasis	0.000183	0.000391	CcSEcCtD
Rifaximin—Feeling abnormal—Dexamethasone—psoriasis	0.000183	0.000391	CcSEcCtD
Rifaximin—Feeling abnormal—Betamethasone—psoriasis	0.000183	0.000391	CcSEcCtD
Rifaximin—Gastrointestinal pain—Betamethasone—psoriasis	0.000182	0.000388	CcSEcCtD
Rifaximin—Gastrointestinal pain—Dexamethasone—psoriasis	0.000182	0.000388	CcSEcCtD
Rifaximin—Vomiting—Mycophenolate mofetil—psoriasis	0.000181	0.000388	CcSEcCtD
Rifaximin—Hypersensitivity—Triamcinolone—psoriasis	0.00018	0.000385	CcSEcCtD
Rifaximin—Rash—Mycophenolate mofetil—psoriasis	0.00018	0.000385	CcSEcCtD
Rifaximin—Dermatitis—Mycophenolate mofetil—psoriasis	0.00018	0.000384	CcSEcCtD
Rifaximin—Headache—Mycophenolate mofetil—psoriasis	0.000179	0.000382	CcSEcCtD
Rifaximin—Malaise—Methotrexate—psoriasis	0.000179	0.000382	CcSEcCtD
Rifaximin—Vertigo—Methotrexate—psoriasis	0.000178	0.00038	CcSEcCtD
Rifaximin—Diarrhoea—Hydrocortisone—psoriasis	0.000178	0.00038	CcSEcCtD
Rifaximin—Urticaria—Dexamethasone—psoriasis	0.000176	0.000377	CcSEcCtD
Rifaximin—Urticaria—Betamethasone—psoriasis	0.000176	0.000377	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000176	0.000377	CcSEcCtD
Rifaximin—Dizziness—Prednisolone—psoriasis	0.000176	0.000376	CcSEcCtD
Rifaximin—Asthenia—Triamcinolone—psoriasis	0.000176	0.000375	CcSEcCtD
Rifaximin—Body temperature increased—Dexamethasone—psoriasis	0.000176	0.000375	CcSEcCtD
Rifaximin—Body temperature increased—Betamethasone—psoriasis	0.000176	0.000375	CcSEcCtD
Rifaximin—Abdominal pain—Betamethasone—psoriasis	0.000176	0.000375	CcSEcCtD
Rifaximin—Abdominal pain—Dexamethasone—psoriasis	0.000176	0.000375	CcSEcCtD
Rifaximin—Insomnia—Prednisone—psoriasis	0.000175	0.000374	CcSEcCtD
Rifaximin—Nausea—Cyclosporine—psoriasis	0.000174	0.000371	CcSEcCtD
Rifaximin—Pruritus—Triamcinolone—psoriasis	0.000173	0.00037	CcSEcCtD
Rifaximin—Cough—Methotrexate—psoriasis	0.000173	0.000369	CcSEcCtD
Rifaximin—Dizziness—Hydrocortisone—psoriasis	0.000172	0.000367	CcSEcCtD
Rifaximin—Nausea—Mycophenolate mofetil—psoriasis	0.000169	0.000362	CcSEcCtD
Rifaximin—Arthralgia—Methotrexate—psoriasis	0.000169	0.00036	CcSEcCtD
Rifaximin—Myalgia—Methotrexate—psoriasis	0.000169	0.00036	CcSEcCtD
Rifaximin—Chest pain—Methotrexate—psoriasis	0.000169	0.00036	CcSEcCtD
Rifaximin—Decreased appetite—Prednisone—psoriasis	0.000168	0.000359	CcSEcCtD
Rifaximin—Rash—Prednisolone—psoriasis	0.000168	0.000359	CcSEcCtD
Rifaximin—Dermatitis—Prednisolone—psoriasis	0.000168	0.000358	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000167	0.000358	CcSEcCtD
Rifaximin—Fatigue—Prednisone—psoriasis	0.000167	0.000356	CcSEcCtD
Rifaximin—Headache—Prednisolone—psoriasis	0.000167	0.000356	CcSEcCtD
Rifaximin—Discomfort—Methotrexate—psoriasis	0.000167	0.000356	CcSEcCtD
Rifaximin—Constipation—Prednisone—psoriasis	0.000165	0.000353	CcSEcCtD
Rifaximin—Vomiting—Hydrocortisone—psoriasis	0.000165	0.000353	CcSEcCtD
Rifaximin—Rash—Hydrocortisone—psoriasis	0.000164	0.00035	CcSEcCtD
Rifaximin—Dermatitis—Hydrocortisone—psoriasis	0.000164	0.00035	CcSEcCtD
Rifaximin—Confusional state—Methotrexate—psoriasis	0.000163	0.000348	CcSEcCtD
Rifaximin—Headache—Hydrocortisone—psoriasis	0.000163	0.000348	CcSEcCtD
Rifaximin—Dizziness—Triamcinolone—psoriasis	0.000162	0.000346	CcSEcCtD
Rifaximin—Anaphylactic shock—Methotrexate—psoriasis	0.000162	0.000345	CcSEcCtD
Rifaximin—Infection—Methotrexate—psoriasis	0.000161	0.000343	CcSEcCtD
Rifaximin—Feeling abnormal—Prednisone—psoriasis	0.000159	0.000341	CcSEcCtD
Rifaximin—Asthenia—Dexamethasone—psoriasis	0.000159	0.000341	CcSEcCtD
Rifaximin—Asthenia—Betamethasone—psoriasis	0.000159	0.000341	CcSEcCtD
Rifaximin—Nervous system disorder—Methotrexate—psoriasis	0.000159	0.000339	CcSEcCtD
Rifaximin—Gastrointestinal pain—Prednisone—psoriasis	0.000158	0.000338	CcSEcCtD
Rifaximin—Nausea—Prednisolone—psoriasis	0.000158	0.000338	CcSEcCtD
Rifaximin—Pruritus—Dexamethasone—psoriasis	0.000157	0.000336	CcSEcCtD
Rifaximin—Pruritus—Betamethasone—psoriasis	0.000157	0.000336	CcSEcCtD
Rifaximin—Skin disorder—Methotrexate—psoriasis	0.000157	0.000336	CcSEcCtD
Rifaximin—Hyperhidrosis—Methotrexate—psoriasis	0.000156	0.000334	CcSEcCtD
Rifaximin—Vomiting—Triamcinolone—psoriasis	0.000156	0.000333	CcSEcCtD
Rifaximin—Nausea—Hydrocortisone—psoriasis	0.000154	0.00033	CcSEcCtD
Rifaximin—Rash—Triamcinolone—psoriasis	0.000154	0.00033	CcSEcCtD
Rifaximin—Dermatitis—Triamcinolone—psoriasis	0.000154	0.00033	CcSEcCtD
Rifaximin—Anorexia—Methotrexate—psoriasis	0.000154	0.000329	CcSEcCtD
Rifaximin—Urticaria—Prednisone—psoriasis	0.000154	0.000328	CcSEcCtD
Rifaximin—Headache—Triamcinolone—psoriasis	0.000153	0.000328	CcSEcCtD
Rifaximin—Body temperature increased—Prednisone—psoriasis	0.000153	0.000327	CcSEcCtD
Rifaximin—Abdominal pain—Prednisone—psoriasis	0.000153	0.000327	CcSEcCtD
Rifaximin—Diarrhoea—Dexamethasone—psoriasis	0.000152	0.000325	CcSEcCtD
Rifaximin—Diarrhoea—Betamethasone—psoriasis	0.000152	0.000325	CcSEcCtD
Rifaximin—Hypotension—Methotrexate—psoriasis	0.000151	0.000323	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000147	0.000315	CcSEcCtD
Rifaximin—Dizziness—Betamethasone—psoriasis	0.000147	0.000314	CcSEcCtD
Rifaximin—Dizziness—Dexamethasone—psoriasis	0.000147	0.000314	CcSEcCtD
Rifaximin—Insomnia—Methotrexate—psoriasis	0.000146	0.000312	CcSEcCtD
Rifaximin—Nausea—Triamcinolone—psoriasis	0.000145	0.000311	CcSEcCtD
Rifaximin—Dyspnoea—Methotrexate—psoriasis	0.000144	0.000308	CcSEcCtD
Rifaximin—Hypersensitivity—Prednisone—psoriasis	0.000143	0.000305	CcSEcCtD
Rifaximin—Vomiting—Betamethasone—psoriasis	0.000141	0.000302	CcSEcCtD
Rifaximin—Vomiting—Dexamethasone—psoriasis	0.000141	0.000302	CcSEcCtD
Rifaximin—Decreased appetite—Methotrexate—psoriasis	0.000141	0.0003	CcSEcCtD
Rifaximin—Rash—Betamethasone—psoriasis	0.00014	0.000299	CcSEcCtD
Rifaximin—Rash—Dexamethasone—psoriasis	0.00014	0.000299	CcSEcCtD
Rifaximin—Dermatitis—Dexamethasone—psoriasis	0.00014	0.000299	CcSEcCtD
Rifaximin—Dermatitis—Betamethasone—psoriasis	0.00014	0.000299	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Methotrexate—psoriasis	0.00014	0.000298	CcSEcCtD
Rifaximin—Fatigue—Methotrexate—psoriasis	0.000139	0.000298	CcSEcCtD
Rifaximin—Headache—Dexamethasone—psoriasis	0.000139	0.000297	CcSEcCtD
Rifaximin—Headache—Betamethasone—psoriasis	0.000139	0.000297	CcSEcCtD
Rifaximin—Asthenia—Prednisone—psoriasis	0.000139	0.000297	CcSEcCtD
Rifaximin—Pain—Methotrexate—psoriasis	0.000138	0.000295	CcSEcCtD
Rifaximin—Pruritus—Prednisone—psoriasis	0.000137	0.000292	CcSEcCtD
Rifaximin—Feeling abnormal—Methotrexate—psoriasis	0.000133	0.000285	CcSEcCtD
Rifaximin—Diarrhoea—Prednisone—psoriasis	0.000132	0.000283	CcSEcCtD
Rifaximin—Gastrointestinal pain—Methotrexate—psoriasis	0.000132	0.000282	CcSEcCtD
Rifaximin—Nausea—Betamethasone—psoriasis	0.000132	0.000282	CcSEcCtD
Rifaximin—Nausea—Dexamethasone—psoriasis	0.000132	0.000282	CcSEcCtD
Rifaximin—Urticaria—Methotrexate—psoriasis	0.000128	0.000274	CcSEcCtD
Rifaximin—Dizziness—Prednisone—psoriasis	0.000128	0.000273	CcSEcCtD
Rifaximin—Abdominal pain—Methotrexate—psoriasis	0.000128	0.000273	CcSEcCtD
Rifaximin—Body temperature increased—Methotrexate—psoriasis	0.000128	0.000273	CcSEcCtD
Rifaximin—Vomiting—Prednisone—psoriasis	0.000123	0.000263	CcSEcCtD
Rifaximin—Rash—Prednisone—psoriasis	0.000122	0.000261	CcSEcCtD
Rifaximin—Dermatitis—Prednisone—psoriasis	0.000122	0.00026	CcSEcCtD
Rifaximin—Headache—Prednisone—psoriasis	0.000121	0.000259	CcSEcCtD
Rifaximin—Hypersensitivity—Methotrexate—psoriasis	0.000119	0.000255	CcSEcCtD
Rifaximin—Asthenia—Methotrexate—psoriasis	0.000116	0.000248	CcSEcCtD
Rifaximin—Nausea—Prednisone—psoriasis	0.000115	0.000246	CcSEcCtD
Rifaximin—Pruritus—Methotrexate—psoriasis	0.000114	0.000244	CcSEcCtD
Rifaximin—Diarrhoea—Methotrexate—psoriasis	0.000111	0.000236	CcSEcCtD
Rifaximin—Dizziness—Methotrexate—psoriasis	0.000107	0.000228	CcSEcCtD
Rifaximin—Vomiting—Methotrexate—psoriasis	0.000103	0.00022	CcSEcCtD
Rifaximin—Rash—Methotrexate—psoriasis	0.000102	0.000218	CcSEcCtD
Rifaximin—Dermatitis—Methotrexate—psoriasis	0.000102	0.000218	CcSEcCtD
Rifaximin—Headache—Methotrexate—psoriasis	0.000101	0.000216	CcSEcCtD
Rifaximin—Nausea—Methotrexate—psoriasis	9.6e-05	0.000205	CcSEcCtD
